Preferred Label : insulin aspart;

MeSH definition : Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.;

MeSH synonym : aspart, insulin; insulin B28asp; B28asp, insulin; B28-Asp-Insulin; B28 asp insulin; insulin, aspartic Acid(B28)-; Insulin-Aspart;

CISMeF synonym : novo nordisk brand of insulin aspart;

MeSH hyponym : NovoLog; NovoRapid;

Wikipedia link : https://en.wikipedia.org/wiki/Insulin aspart;

Is substance : O;

UNII : D933668QVX;

Details


Main resources

You can consult :

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

https://www.ema.europa.eu/en/medicines/human/EPAR/truvelog-mix-30
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
insulin aspart
insulin aspart
insulin aspart
biosimilar pharmaceuticals
diabetes mellitus
adolescent
adult
aged
drug approval
europe
pregnancy
breast feeding
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
product surveillance, postmarketing
insulin aspart, insulin aspart protamine drug combination 30:70
drug interactions

---
Kirsty (previously Kixelle)
https://www.ema.europa.eu/en/medicines/human/EPAR/kixelle
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin aspart
insulin aspart
biosimilar pharmaceuticals
insulin aspart
diabetes mellitus
child
infant
adolescent
adult
aged
injections, subcutaneous
infusions, subcutaneous
infusions, intravenous
hypoglycemic agents
hypoglycemic agents
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3197626/fr/fiasp
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
insulin aspart
hypoglycemic agents
injections, subcutaneous
insulin aspart
adolescent
child
diabetes mellitus, type 1
diabetes mellitus, type 2

---
https://www.has-sante.fr/jcms/p_3201468/fr/fiasp-pumpcart
2020
false
false
false
France
insulin aspart
diabetes mellitus
insurance, health, reimbursement
insulin aspart

---
https://www.ema.europa.eu/en/medicines/human/EPAR/insulin-aspart-sanofi
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
insulin aspart
insulin aspart
hypoglycemic agents
hypoglycemic agents
biosimilar pharmaceuticals
injections, subcutaneous
child
adolescent
adult
aged
diabetes mellitus
insulin aspart
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding

---
http://www.has-sante.fr/portail/jcms/c_2762817/fr/novorapid
2017
false
false
false
France
French
evaluation of the transparency committee
insulin aspart

---
https://www.ema.europa.eu/medicines/human/EPAR/Fiasp
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
insulin aspart
insulin aspart
drug approval
europe
treatment outcome
product surveillance, postmarketing
diabetes mellitus
injections, subcutaneous
adult
aged
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
insulin aspart

---
http://www.has-sante.fr/portail/jcms/c_2043747/fr/novorapid-novomix
http://www.has-sante.fr/portail/jcms/c_1278896/novorapid-novomix
2015
false
France
French
evaluation of the transparency committee
insulin aspart
hypoglycemic agents
insurance, health, reimbursement
injections, subcutaneous
adult
adolescent
child
diabetes mellitus
insulin aspart
insulin, isophane
biphasic insulins
insulin aspart
treatment outcome
randomized controlled trials as topic

---
https://www.ema.europa.eu/medicines/human/EPAR/Ryzodeg
2013
false
United Kingdom
English
French
insulin degludec and insulin aspart
insulin degludec, insulin aspart drug combination
insulin degludec, insulin aspart drug combination
insulin aspart
drug combinations
drug approval
europe
treatment outcome
insulin, long-acting
insulin, long-acting
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
diabetes mellitus, type 1
diabetes mellitus, type 2
summary of product characteristics
package leaflet
drug evaluation
syndication feed
recombinant proteins
adult
aged
drug interactions
pregnancy
breast feeding
fertility
randomized controlled trials as topic
Glycated Hemoglobin
drug combinations
drug combinations
insulin aspart
insulin degludec
insulin degludec

---
https://www.ema.europa.eu/medicines/human/EPAR/NovoRapid
2013
United Kingdom
French
English
syndication feed
adolescent
child
adult
aged
diabetes mellitus
hypoglycemic agents
hypoglycemic agents
drug interactions
treatment outcome
drug evaluation
drug approval
drug labeling
injections, subcutaneous
pregnancy
breast feeding
infusions, intravenous
insulin aspart
insulin aspart
insulin aspart
recombinant proteins
drug evaluation
summary of product characteristics
package leaflet

---
https://rmlg.uliege.be/article/1822
2008
Belgium
French
insulin aspart
biphasic insulins
insulin aspart
diabetes mellitus, type 2
hypoglycemic agents
injections, subcutaneous
belgium
insulin, isophane
journal article
drug information

---
https://www.ema.europa.eu/medicines/human/EPAR/NovoMix
2008
United Kingdom
French
English
syndication feed
insulin aspart
insulin aspart
biphasic insulins
biphasic insulins
hypoglycemic agents
diabetes mellitus
hypoglycemic agents
treatment outcome
drug evaluation
protamines
drug combinations
insulin aspart
insulin, isophane
insulin, isophane
injections, subcutaneous
insulin aspart, insulin aspart protamine drug combination 30:70
insulin aspart, insulin aspart protamine drug combination 30:70
package leaflet
drug evaluation
summary of product characteristics

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_NovoMix30-Fr.pdf
2006
Canada
French
biphasic insulins
insulin aspart
protamines
drug combinations
canada
diabetes mellitus
hypoglycemic agents
insulin aspart
insulin, isophane
insulin aspart, insulin aspart protamine drug combination 30:70
drug evaluation

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.